Endospan Announces Positive 1 YR Data from TRIOMPHE FDA Pivotal Study For the NEXUS® Aortic Arch Stent-Graft System

The one-year results for the 94 high surgical risk patients in the three arms are promising for aortic arch treatment in Zone 0, a very difficult segment of the aorta to treat without high rates of co-morbidities such as mortality or stroke